Center for Biologics Evaluation and Research (CBER)

Healthcare attorney Michael Werner will participate in the Food and Drug Law Institute (FDLI) Annual Conference, which will address policy issues in all facets of industries regulated by the U.S. Food and Drug Administration (FDA). The conference will provide in-depth discussions and analysis on a wide variety of timely topics by bringing together professionals from the federal government, healthcare industry, private bar and nonprofits, as well as patient and consumer advocates. Mr. Werner will address the top issues the Center for Biologics Evaluation and Research (CBER) is facing as well as priorities and goals for the coming year.